EP1077989A4 - Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene - Google Patents
Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed geneInfo
- Publication number
- EP1077989A4 EP1077989A4 EP99921914A EP99921914A EP1077989A4 EP 1077989 A4 EP1077989 A4 EP 1077989A4 EP 99921914 A EP99921914 A EP 99921914A EP 99921914 A EP99921914 A EP 99921914A EP 1077989 A4 EP1077989 A4 EP 1077989A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- new
- associated antigen
- tumor associated
- expressed gene
- ubiquitously expressed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/56—Kidney
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8531898P | 1998-05-13 | 1998-05-13 | |
US85318P | 1998-05-13 | ||
PCT/US1999/010424 WO1999058546A1 (en) | 1998-05-13 | 1999-05-13 | Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1077989A1 EP1077989A1 (en) | 2001-02-28 |
EP1077989A4 true EP1077989A4 (en) | 2002-01-02 |
Family
ID=22190806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99921914A Withdrawn EP1077989A4 (en) | 1998-05-13 | 1999-05-13 | Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1077989A4 (en) |
JP (1) | JP2002514400A (en) |
AU (1) | AU3900399A (en) |
CA (1) | CA2328405A1 (en) |
WO (1) | WO1999058546A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3231442B1 (en) * | 2006-06-23 | 2019-12-25 | ADC Therapeutics SA | Polynucleotides and polypeptide sequences involved in cancer |
CN102245773B (en) | 2008-11-03 | 2014-08-27 | 阿莱斯亚生物疗法股份有限公司 | Antibodies that specifically block the biological activity of a tumor antigen |
BR112013025198A2 (en) | 2011-03-31 | 2018-12-04 | Alethia Biotherapeutics Inc. | kidney-associated antigen 1 antibodies and antigen-binding fragments thereof |
KR102102239B1 (en) | 2012-01-09 | 2020-04-21 | 에이디씨 테라퓨틱스 에스에이 | Method for treating breast cancer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996010577A1 (en) * | 1994-09-30 | 1996-04-11 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
WO1996029409A2 (en) * | 1995-03-21 | 1996-09-26 | Ludwig Institute For Cancer Research | Rage tumor rejection antigens |
-
1999
- 1999-05-13 WO PCT/US1999/010424 patent/WO1999058546A1/en not_active Application Discontinuation
- 1999-05-13 EP EP99921914A patent/EP1077989A4/en not_active Withdrawn
- 1999-05-13 CA CA002328405A patent/CA2328405A1/en not_active Abandoned
- 1999-05-13 JP JP2000548350A patent/JP2002514400A/en active Pending
- 1999-05-13 AU AU39003/99A patent/AU3900399A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996010577A1 (en) * | 1994-09-30 | 1996-04-11 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
WO1996029409A2 (en) * | 1995-03-21 | 1996-09-26 | Ludwig Institute For Cancer Research | Rage tumor rejection antigens |
Non-Patent Citations (1)
Title |
---|
See also references of WO9958546A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1077989A1 (en) | 2001-02-28 |
WO1999058546A1 (en) | 1999-11-18 |
JP2002514400A (en) | 2002-05-21 |
CA2328405A1 (en) | 1999-11-18 |
AU3900399A (en) | 1999-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9811820B (en) | Interlocking tiles. | |
GB9930397D0 (en) | Profile formation | |
EP1062191A4 (en) | Alkylaromatics production | |
GB9901348D0 (en) | Intelligent production riser | |
EP1077989A4 (en) | Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene | |
PL340374A1 (en) | Tanatin encoding gene | |
AU2001289674A1 (en) | New nucleotide sequences coding for the lysr1 gene | |
GB9804065D0 (en) | Tumour associated antigen 791Tgp72 | |
EP1027929A4 (en) | Catalyst for the production of acrylonitrile | |
HU0100131D0 (en) | Novel nucleotide sequences coding for the ptsh-gene | |
HUP0004027A2 (en) | New tissue-specific calpaines, their production and their use | |
GB2332164A9 (en) | Continuous band manufacture | |
AU2001289807A1 (en) | Nucleotide sequences coding for the pstc2 gene | |
ZA200007078B (en) | New nucleotide sequences coding for the glk-gene. | |
AU2001279804A1 (en) | Nucleotide sequences coding for the hisc2 gene | |
EP1063290A4 (en) | Novel dicarbonylreductase and gene encoding the same | |
AU2001293723A1 (en) | Nucleotide sequences coding for the dep33 gene | |
EP1069186A4 (en) | Gene encoding desulfurases | |
GB2382832B (en) | Profile formation | |
TW328844U (en) | Intelligent detachable hard disk case | |
AU5443099A (en) | Gene encoding cdw108 | |
GB9617881D0 (en) | Interlocking brick | |
IL148104A0 (en) | Polycarbonate slabs | |
EP1225220A4 (en) | Dna encoding endo-beta-galactosidase | |
PL346375A1 (en) | Method of terminating the ends of protectively braided ropes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20001122 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20011113 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7C 07H 21/02 A, 7C 12Q 1/68 B, 7C 12P 21/04 B, 7C 12N 1/20 B, 7C 12N 15/00 B, 7C 07K 14/47 B |
|
17Q | First examination report despatched |
Effective date: 20021210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030422 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1033322 Country of ref document: HK |